The following data is part of a premarket notification filed by Biowave Corporation with the FDA for Deepwave Percutaneous Neuromodulation Pain Therapy System.
Device ID | K061166 |
510k Number | K061166 |
Device Name: | DEEPWAVE PERCUTANEOUS NEUROMODULATION PAIN THERAPY SYSTEM |
Classification | Stimulator, Nerve, Electrical, Percutaneous (pens), For Pain Relief |
Applicant | BIOWAVE CORPORATION 49 PLAIN STREET North Attleboro, MA 02760 |
Contact | Mary Mcnamara-cullinane |
Correspondent | Mary Mcnamara-cullinane BIOWAVE CORPORATION 49 PLAIN STREET North Attleboro, MA 02760 |
Product Code | NHI |
CFR Regulation Number | 882.5890 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2006-04-27 |
Decision Date | 2006-08-15 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00859911006065 | K061166 | 000 |
10859911006024 | K061166 | 000 |
20859911006007 | K061166 | 000 |